Agency: Food and Drug Administration
Pages: 1
[FR Doc E7-8784] 1. General and Plastic Surgery Devices; Reclassification of the Absorbable
The Food and Drug Administration (FDA) is reopening until June 7, 2007, the comment period for the proposed rule, published in the Federal Register of October 31, 2006 (71 FR 63278). The proposed rule would reclassify the absorbable hemostatic device intended to produce hemostasis from class III (premarket approval) into class II (special
Published: 2007-05-08 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc E7-8783] 2. Agency Information Collection Activities; Submission for Office of Management
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Published: 2007-05-08 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc E7-8780] 3. Draft Guidance for Industry and Food and Drug Administration Staff; Class II
The Food and Drug Administration (FDA) is reopening until June 7, 2007, the comment period for a draft guidance entitled ``Class II Special Controls Guidance Document: Absorbable Hemostatic Device.'' FDA published a notice of availability of the draft guidance in the Federal Register of October 31, 2006 (71 FR 63774). The draft guidance describes
Published: 2007-05-08 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc E7-8781] 4. Voluntary Self-Inspection of Medicated Feed Manufacturing Facilities; Draft
The Food and Drug Administration (FDA) is reopening to June 8, 2007, the comment period for the notice of availability that appeared in the Federal Register of February 12, 2007 (72 FR 6572). In the notice, FDA requested comments on the draft compliance policy guide on voluntary selfinspection of medicated feed manufacturing facilities. The agency
Published: 2007-05-08 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
Pages: 1